Substituted tetracycline compounds for treatment of inflammatory skin disorders

Inventors

Assefa, Haregewein • Bhatia, Beena • DRAPER, MICHAEL P. • Honeyman, Laura • Kim, Oak • Molnar, Dennis P.

Assignees

Paratek Pharmaceuticals Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-8513223-B2

Patent

Publication Date

2013-08-20

Expiration Date


Abstract

Methods and compositions for the treatment of skin disorders (e.g., acne, rosacea) are described.

Core Innovation

The invention provides methods for treating a subject suffering from an inflammatory skin disorder by administering an effective amount of a substituted tetracycline compound of formula I, or a pharmaceutically acceptable salt thereof. The disclosure identifies pharmaceutical compositions comprising substituted tetracyclines of formulas I–VI, including 9-aminoalkyl, heteroaryl, cyano/amino, and cyclobutenedione-substituted derivatives. These compositions are formulated for topical, oral, or parenteral administration, either alone or in combination with a second agent.

The targeted inflammatory skin disorders include acne and rosacea. The substituted tetracycline compounds exhibit narrow-spectrum antibacterial activity against gram-positive organisms alongside anti-inflammatory activity, including reduction of carrageenan-induced paw inflammation. Furthermore, the compounds demonstrate potential for reduced phototoxicity relative to doxycycline and exhibit greater oxidative stability or lower oxidative potential than minocycline.

Claims Coverage

The claims identify one independent claim directed to treating an inflammatory skin disorder, comprising two inventive features.

Treatment of an inflammatory skin disorder

Administering an effective amount of a substituted tetracycline compound to a subject suffering from an inflammatory skin disorder, such that the disorder is treated.

Substituted tetracycline compound of formula I

The administered substituted tetracycline compound is a compound of formula I, or a pharmaceutically acceptable salt thereof, with substituents defined in the claim.

The claim covers administering an effective amount of a defined substituted tetracycline compound of formula I or a pharmaceutically acceptable salt thereof to treat an inflammatory skin disorder.

Stated Advantages

The compounds exhibit narrow-spectrum antibacterial activity against gram-positive bacteria and demonstrate anti-inflammatory activity, with compounds A and P reducing carrageenan-induced paw inflammation compared with controls.

The compounds demonstrate potential for reduced phototoxicity relative to doxycycline.

The compounds demonstrate greater oxidative stability or lower oxidative potential than minocycline.

Documented Applications

Treatment of inflammatory skin disorders, including acne and rosacea, using substituted tetracycline compounds or their pharmaceutically acceptable salts.

Topical, oral, or parenteral administration of substituted tetracycline compounds, administered alone or in combination with a second agent.

Pharmaceutical compositions comprising substituted tetracyclines, optionally administered with a second agent, for treating inflammatory skin disorders.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.